Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort studyTimo Mayerhöfer, Nina Buchtele, D Friès et al.|Thrombosis Research|2024Cited by 5
Outcome of COVID-19 patients treated with VV-ECMO in Tyrol during the pandemicAndreas Peer, Michael Joannidis, Fabian Perschinka et al.|Wiener klinische Wochenschrift|2023Cited by 2